KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Bristol Myers Squibb (BMY) over the last 17 years, with Q3 2025 value amounting to -$240.0 million.

  • Bristol Myers Squibb's Other Working Capital Changes fell 4371.26% to -$240.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$128.0 million, marking a year-over-year increase of 2967.03%. This contributed to the annual value of -$624.0 million for FY2024, which is 19355.32% down from last year.
  • According to the latest figures from Q3 2025, Bristol Myers Squibb's Other Working Capital Changes is -$240.0 million, which was down 4371.26% from -$222.0 million recorded in Q2 2025.
  • Bristol Myers Squibb's 5-year Other Working Capital Changes high stood at $1.1 billion for Q1 2022, and its period low was -$725.0 million during Q4 2024.
  • Moreover, its 5-year median value for Other Working Capital Changes was -$167.0 million (2024), whereas its average is $79.7 million.
  • In the last 5 years, Bristol Myers Squibb's Other Working Capital Changes surged by 18526.79% in 2022 and then plummeted by 38305.08% in 2024.
  • Quarter analysis of 5 years shows Bristol Myers Squibb's Other Working Capital Changes stood at -$272.0 million in 2021, then crashed by 157.35% to -$700.0 million in 2022, then soared by 59.57% to -$283.0 million in 2023, then plummeted by 156.18% to -$725.0 million in 2024, then skyrocketed by 66.9% to -$240.0 million in 2025.
  • Its Other Working Capital Changes stands at -$240.0 million for Q3 2025, versus -$222.0 million for Q2 2025 and $1.1 billion for Q1 2025.